MétaCan
Menu
← Back to cohort
Record W4404527351 · doi:10.1073/pnas.2406239121

Small-molecule disruption of androgen receptor–dependent chromatin clusters

2024· article· en· W4404527351 on OpenAlexaff
Sarah E. Kohrt, EK Novak, Subhashish Tapadar, Bocheng Wu, Jonathan D. Strope, Yaw Asante, Hyunmin Kim, Matthew S. Chang, D. Gurdak, Athar Khalil, Michael P. Rood, Eric D. Raftery, Diana A. Stavreva, Holly M. Nguyen, Lisha G. Brown, Maddy Ramser, Cody J. Peer, Warren M. Meyers, Nicholas Aboreden, Maharshi Chakraborty, Richard Sallari, Peter S. Nelson, Kathleen Kelly, Thomas G.W. Graham, Xavier Darzacq, William D. Figg, Adegboyega K. Oyelere, Eva Corey, Remi Adelaiye‐Ogala, Berkley E. Gryder

Bibliographic record

VenueProceedings of the National Academy of Sciences · 2024
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Treatment and Research
Canadian institutionsUniversity of British Columbia
FundersNational Institutes of HealthInstitute for Bioengineering and BiosciencesKaleida Health FoundationU.S. Department of DefenseGeorgia Institute of TechnologyCase Comprehensive Cancer Center, Case Western Reserve UniversityUniversity at BuffaloUniversity of WashingtonNational Cancer InstituteCase Western Reserve UniversityItä-Suomen YliopistoPerelman School of Medicine, University of PennsylvaniaUniversitat de BarcelonaUniversity of PennsylvaniaProstate Cancer FoundationSchool of Medicine, Case Western Reserve University
KeywordsAndrogen receptorEnzalutamideChromatinEnhancerEpigenomeProstate cancerCancer researchBiologyChromatin immunoprecipitationPromoterCell biologyAndrogenGeneChemistryComputational biologyGene expressionCancerEndocrinologyGeneticsDNA methylationHormone

Abstract

fetched live from OpenAlex

Sustained androgen receptor (AR) signaling during relapse is a central driver of metastatic castration-resistant prostate cancer (mCRPC). Current AR antagonists, such as enzalutamide, fail to provide long-term benefit for the mCRPC patients who have dramatic increases in AR expression. Here, we report AR antagonists with efficacy in AR-overexpressing models. These molecules bind to the ligand-binding domain of the AR, promote AR localization to the nucleus, yet potently and selectively down-regulate AR-target genes. The molecules BG-15a and the pharmacokinetically optimized BG-15n elicit a decrease in cell and tumor growth in vitro and in vivo in models of mCRPC. BG-15a/n treatment causes the collapse of chromatin loops between enhancers and promoters at key genes in the AR-driven epigenome. AR binding in the promoter, as well as 3D chromatin clustering, is needed for genes to respond. BG-15a/n represent promising agents for treating patients with relapsed AR-driven mCRPC tumors.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.064
GPT teacher head0.356
Teacher spread0.292 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueProceedings of the National Academy of Sciences→Same topicProstate Cancer Treatment and Research→French-language works237,207→